Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981578 · ClinicalTrials.gov registry record · NA
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
A NA study, sponsored by InSightec.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00981578: Clinical Trial NA study, sponsored by InSightec.
NCT00981578 is a NA study that was terminated before completion, run by InSightec. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00981578, a NA study, was terminated before completion, sponsored by InSightec.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.
Primary Outcome
Adverse effects outcomes are reported in the adverse events module.
Interventions
- DEVICE ExAblate 2100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-11-14 |
| Phase | NA |
Why NCT00981578 stopped before completion
NCT00981578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which ExAblate 2100 is the first listed.
NCT00981578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00981578 about?
NCT00981578 is a clinical study titled "ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain". A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.
What is the current status of trial NCT00981578?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2009-09. Estimated completion is 2016-11-14.
What interventions are being tested in trial NCT00981578?
The interventions under investigation include: ExAblate 2100 (DEVICE).
Who is sponsoring clinical trial NCT00981578?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00981578's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia